DK1062341T3 - Muterede rekombinante allergener - Google Patents

Muterede rekombinante allergener

Info

Publication number
DK1062341T3
DK1062341T3 DK99907345T DK99907345T DK1062341T3 DK 1062341 T3 DK1062341 T3 DK 1062341T3 DK 99907345 T DK99907345 T DK 99907345T DK 99907345 T DK99907345 T DK 99907345T DK 1062341 T3 DK1062341 T3 DK 1062341T3
Authority
DK
Denmark
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
DK99907345T
Other languages
Danish (da)
English (en)
Inventor
Michael Dho Spangfort
Joergen Nedergaard Larsen
Hans Henrik Ipsen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1062341(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Application granted granted Critical
Publication of DK1062341T3 publication Critical patent/DK1062341T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99907345T 1998-03-16 1999-03-16 Muterede rekombinante allergener DK1062341T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16
PCT/DK1999/000136 WO1999047680A1 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens

Publications (1)

Publication Number Publication Date
DK1062341T3 true DK1062341T3 (da) 2008-11-03

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99907345T DK1062341T3 (da) 1998-03-16 1999-03-16 Muterede rekombinante allergener

Country Status (19)

Country Link
US (1) US20040091500A1 (enExample)
EP (1) EP1062341B1 (enExample)
JP (1) JP2002506648A (enExample)
KR (1) KR20010041918A (enExample)
CN (1) CN1332029C (enExample)
AT (1) ATE408690T1 (enExample)
AU (1) AU749749B2 (enExample)
CA (1) CA2323687C (enExample)
DE (1) DE69939584D1 (enExample)
DK (1) DK1062341T3 (enExample)
ES (1) ES2313776T3 (enExample)
HU (1) HUP0101464A3 (enExample)
IL (2) IL138339A0 (enExample)
NO (1) NO328354B1 (enExample)
NZ (1) NZ506665A (enExample)
PL (1) PL194804B1 (enExample)
PT (1) PT1062341E (enExample)
WO (1) WO1999047680A1 (enExample)
ZA (1) ZA200004819B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001254623A1 (en) * 2000-04-28 2001-11-12 Novozymes A/S Production and use of protein variants having modified immunogenicity
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
DK1340085T3 (da) * 2000-10-17 2008-12-01 Besst Test Aps Assay til direkte detektion af en biologisk celle i en legemsvæskepröve
ATE414773T1 (de) * 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
ATE347376T1 (de) * 2000-12-28 2006-12-15 Biomay Prod & Handel Behandlung von allergien
DE60234475D1 (de) * 2001-03-02 2009-12-31 Univ Rockefeller Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
EP1436627A2 (en) * 2001-10-05 2004-07-14 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
JP4343702B2 (ja) * 2002-02-27 2009-10-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 低アレルギー性シラカバ花粉主要アレルゲンｒＢｅｔｖ１の製造方法
EP1504089A2 (en) * 2002-05-16 2005-02-09 Alk Abell A/S Allergen mutants
US7384635B2 (en) * 2002-11-01 2008-06-10 Alk-Abello A/S Protein variants of naturally occurring allergens
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
WO2004075875A1 (en) 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CA2548249C (en) 2003-12-19 2013-02-12 Alk-Abello A/S Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
US20090155351A1 (en) 2005-10-04 2009-06-18 Alk-Abello A/S Solid Vaccine Formulation
ITMI20052517A1 (it) 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
EP2010645A4 (en) * 2006-04-20 2009-05-06 Univ Singapore RECOMBINANT LACTOBACILLUS AND USE THEREOF
CA2678353A1 (en) * 2007-02-15 2008-08-21 Mannkind Corporation A method for enhancing t cell response
CA2682054A1 (en) 2007-03-28 2008-10-02 Alk-Abello A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
ES2606550T3 (es) 2009-06-19 2017-03-24 Alk-Abelló S.A. Nueva manera de administrar alérgeno en inmunoterapia específica con alérgenos
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
US20220387316A1 (en) * 2019-11-13 2022-12-08 The Regents Of The University Of Michigan Nanoemulsion compositions for treating aeroallergen associated allergy and inflammation
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
WO1999038978A1 (en) * 1998-01-31 1999-08-05 University Of Arkansas Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
NO20004614D0 (no) 2000-09-15
PL343029A1 (en) 2001-07-30
HUP0101464A2 (hu) 2001-08-28
PT1062341E (pt) 2008-12-24
JP2002506648A (ja) 2002-03-05
NO328354B1 (no) 2010-02-01
WO1999047680A1 (en) 1999-09-23
DE69939584D1 (de) 2008-10-30
EP1062341A1 (en) 2000-12-27
CA2323687C (en) 2008-11-25
CN1332029C (zh) 2007-08-15
HK1033591A1 (en) 2001-09-07
ES2313776T3 (es) 2009-03-01
IL138339A (en) 2009-06-15
PL194804B1 (pl) 2007-07-31
EP1062341B1 (en) 2008-09-17
NZ506665A (en) 2003-08-29
IL138339A0 (en) 2001-10-31
KR20010041918A (ko) 2001-05-25
ZA200004819B (en) 2001-05-30
ATE408690T1 (de) 2008-10-15
AU749749B2 (en) 2002-07-04
CN1293710A (zh) 2001-05-02
US20040091500A1 (en) 2004-05-13
NO20004614L (no) 2000-10-26
CA2323687A1 (en) 1999-09-23
HUP0101464A3 (en) 2004-10-28
AU2714799A (en) 1999-10-11

Similar Documents

Publication Publication Date Title
DK1062341T3 (da) Muterede rekombinante allergener
DK1373510T3 (da) Mutante allergener
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
DE69736984D1 (de) Inhibitoren des interleukin-1-beta konvertierenden enzyms
AU3227700A (en) Skin sanitizing compositions
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
BG102818A (en) D-manitol and method for its preparation
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
EA200000086A1 (ru) Алатрофлоксациновые парентеральные составы
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
WO2004004649A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001016319A3 (en) Compositions and methods for the treatment of immune related diseases
DE602004022323D1 (de) Tyrosinasemutante und verfahren zur verwendung davon
IT1294932B1 (it) Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
WO2001048205A3 (en) Murine neu sequences and methods of use therefor